Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision

NCT05800301 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Retinitis Pigmentosa

Interventions

BIOLOGICAL: Wharton's jelly derived mesenchymal stemcells
DEVICE: Magnovision

Sponsor

Ankara Universitesi Teknokent